Numerai’s Elevance Health ELV Stock Holding History

Numerai’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,272	Closed	-$734K	–	658
2025 Q3	$734K	Buy	+2,272	New	+$707K	0.1%	260
2025 Q1	–	Sell	-2,078	Closed	-$767K	–	516
2024 Q4	$767K	Buy	+2,078	New	+$870K	0.21%	179

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Numerai's ELV Position: Q4 2025 in Review

Numerai sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 2,272 shares — an estimated $734K sold.

Numerai first reported a position in ELV in Q4 2024 and held it in 2 quarters. The position peaked at $767K in Q4 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

Numerai reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
Numerai sold 2,272 Elevance Health shares in Q4 2025, an estimated $734K.
Numerai first reported a position in Elevance Health in Q4 2024 and held it in 2 quarters.
Numerai's Elevance Health position peaked at $767K in Q4 2024.
1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Numerai's 13F filing for Q4 2025, filed 17 Feb 2026.